Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overexpression of kynurenic acid in stroke: An endogenous neuroprotector?

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·2017
Same author

3-hydroxi-anthranilic acid is early expressed in stroke.

European journal of histochemistry : EJH·2017
Same author

NO-tryptophan: a new small molecule located in the rat brain.

European journal of histochemistry : EJH·2016
Same author

Developmental study of vitamin C distribution in children's brainstems by immunohistochemistry.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·2015
Same author

Distribution of GABA-immunoreactive neurons in the forebrain of the goldfish, Carassius auratus.

Cell and tissue research·2013
Same author

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes.

Acta psychiatrica Scandinavica·2012

Related Experiment Video

Updated: Jun 12, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Antisera against small neurotransmitter-like molecules.

M Geffard1, A M Henrich-Rock, J Dulluc

  • 1Institut de Biochimie Cellulaire et Neurochimie du CNRS and U 259 INSERM, Rue Camille Saint-Saëns, 33077 Bordeaux Cedex, France.

Neurochemistry International
|May 25, 2010
PubMed
Summary

Researchers developed specific antisera for key neurotransmitters like indolealkylamines, catecholamines, and GABA. In vitro tests confirmed each antibody accurately targets its intended small molecule neurotransmitter.

More Related Videos

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
18:01

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

Related Experiment Videos

Last Updated: Jun 12, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
18:01

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Small neurotransmitter-like molecules, including indolealkylamines, catecholamines, and amino acid derivatives (e.g., GABA), play critical roles in neuronal signaling.
  • Developing specific antibodies against these small molecules is essential for their detection and quantification in biological systems.
  • Existing methods may lack the specificity required for precise analysis of these neurotransmitter classes.

Purpose of the Study:

  • To produce and characterize antisera against three major classes of small neurotransmitter-like molecules.
  • To evaluate the specificity and affinity of the generated antibodies for their respective target molecules.
  • To establish reliable immunological tools for studying neurotransmitter function.

Main Methods:

  • Production of antisera against indolealkylamines, catecholamines, and GABA derivatives.
  • Specificity assessment using radioimmunological and immunoenzymatic competition assays.
  • Characterization of antibody binding sites through cross-reactivity ratios and affinity constant determination.
  • In vitro validation of antibody performance.

Main Results:

  • Successfully generated antisera against indolealkylamines, catecholamines, and GABA.
  • Competition assays demonstrated high specificity, with minimal cross-reactivity between different neurotransmitter classes.
  • Affinity constants and cross-reactivity ratios confirmed the precise binding of each antiserum to its target molecule.
  • All immune responses were validated as specific for their intended small molecule neurotransmitter.

Conclusions:

  • The developed antisera exhibit high specificity for indolealkylamines, catecholamines, and GABA.
  • These validated antisera are suitable for use in various immunological assays for neurotransmitter research.
  • The findings provide reliable tools for investigating the roles of these small molecule neurotransmitters in biological systems.